Cite
HARVARD Citation
Sebert, M. et al. (n.d.). Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment. Leukemia research. pp. S54-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sebert, M. et al. (n.d.). Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment. Leukemia research. pp. S54-. [Online].